Overview

Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

Status:
Completed

Trial end date:
2017-08-01

Target enrollment:

Participant gender:

Summary

The use of corifollitropin alfa is superior in terms of pregnancy outcome parameters as compared to recombinant follicle stimulating hormone (FSH) during ovarian stimulation protocols in women undergoing in vitro fertilisation.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

National and Kapodistrian University of Athens

Treatments:

Follicle Stimulating Hormone
Hormones